Tetra Bio-Pharma Inc. — Form D
Tetra Bio-Pharma Inc. of ORLEANS, ONTARIO, Z4, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-12. The offering totals $371K, of which $371K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-06-12
- Form: D
- Accession: 0001814888-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $371K
- Amount sold: $371K
- Investors: 1
- Date of first sale: 2020-05-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-368793
Issuer
- Name: Tetra Bio-Pharma Inc.
- CIK: 0001814888
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 2316 ST. JOSEPH BLVD., ORLEANS, ONTARIO, Z4, K1C 1E8
- Phone: 438-899-7575
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| BILL CHELIAK | Director | ORLEANS, ONTARIO, Z4 |
| GREGORY DROHAN | Director | ORLEANS, ONTARIO, Z4 |
| CARL MERTON | Director | ORLEANS, ONTARIO, Z4 |
| GUY CHAMBERLAND | Executive Officer | ORLEANS, ONTARIO, Z4 |
| Sabino Di Paola | Executive Officer | Ottawa, A6 |
More